معرفی
Dr. Alison Hole is a researcher affiliated with Newcastle University, specializing in biochemical and structural studies of cyclin-dependent kinases (CDKs) and their inhibitors. Her work focuses on the molecular mechanisms of CDKs in transcription regulation and cancer therapy.
- Key Collaborators: Professor Jane Endicott, Professor Martin Noble, Dr. Sonja Baumli
- Major Research Themes: Conformational dynamics of CDKs, inhibitor selectivity, transcription elongation pathways, and apoptosis in neuroblastoma cells
Her research has implications for drug design targeting CDKs in oncology and transcriptional diseases.
Publication Trends: Recent studies highlight the structural basis of CDK9 inhibitor selectivity, ATP-binding site variability across regulatory states, and the role of CDK tails in reaction pathways. These works intersect with cancer biology, pharmacology, and protein engineering.
Collaborative Network: Intensive co-authorship with senior academics (e.g., Professors Endicott and Noble) suggests integration into a multidisciplinary research team focused on kinase inhibition.
